Identification of a functional estrogen‐responsive enhancer element in the promoter 2 of PRDM2 gene in breast cancer cell lines

The retinoblastoma protein‐interacting zinc‐finger (RIZ) gene, also known as PRDM2, encodes two protein products, RIZ1 and RIZ2, differing for the presence of a 202 aa domain, called PR domain, at the N‐terminus of the RIZ1 molecule. While the histone H3 K9 methyltransferase activity of RIZ1 is associated with the negative control of cell proliferation, no information is currently available on either expression regulation of the RIZ2 form or on its biological activity. RIZ proteins act as ER co‐activators and promote optimal estrogen response in female reproductive tissues. In estrogen‐responsive cells, 17‐β estradiol modulates RIZ gene expression producing a shift in the balanced expression of the two forms. Here, we demonstrate that an estrogen‐responsive element (ERE) within the RIZ promoter 2 is regulated in a ligand‐specific manner by ERα, through both the AF1 and AF2 domains. The pattern of ERα binding, histone H4 acetylation, and histone H3 cyclical methylation of lysine 9 was comparable to other estrogen‐regulated promoters. Association of topoisomerase IIβ with the RIZ promoter 2 confirmed the transcriptional activation induced by estrogen. We hypothesize that RIZ2, acting as a negative regulator of RIZ1 function, mediates the proliferative effect of estrogen through regulation of survival and differentiation gene expression. J. Cell. Physiol. 227: 964–975, 2012. © 2011 Wiley Periodicals, Inc.

[1]  J. Gu,et al.  A Histone Methyltransferase Is Required for Maximal Response to Female Sex Hormones , 2004, Molecular and Cellular Biology.

[2]  Hoguen Kim,et al.  Frequent frameshift mutations of RIZ in sporadic gastrointestinal and endometrial carcinomas with microsatellite instability. , 2000, Cancer research.

[3]  Heike Brand,et al.  Estrogen Receptor-α Directs Ordered, Cyclical, and Combinatorial Recruitment of Cofactors on a Natural Target Promoter , 2003, Cell.

[4]  T. Ince,et al.  A Conserved Downstream Element Defines a New Class of RNA Polymerase II Promoters (*) , 1995, The Journal of Biological Chemistry.

[5]  J. Sheu,et al.  Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. , 2001, Cancer research.

[6]  L. Altucci,et al.  17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. , 1996, Oncogene.

[7]  S. Minucci,et al.  Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice. , 2007, The Journal of clinical investigation.

[8]  P. Chambon,et al.  Functional domains of the human estrogen receptor , 1987, Cell.

[9]  K. Wright,et al.  Identification of a Functionally Impaired Positive Regulatory Domain I Binding Factor 1 Transcription Repressor in Myeloma Cell Lines1 , 2003, The Journal of Immunology.

[10]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Bontempo,et al.  Differentiation of Myeloid Cell Lines Correlates with a Selective Expression of RIZ Protein , 2001, Molecular medicine.

[12]  G. Puca,et al.  Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation. , 2005, Experimental cell research.

[13]  A. Bilancio,et al.  Src Is an Initial Target of Sex Steroid Hormone Action , 2002, Annals of the New York Academy of Sciences.

[14]  V. Moudgil,et al.  Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells , 1999, Oncogene.

[15]  L. Liu,et al.  Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1 , 1999, International journal of cancer.

[16]  J. Gustafsson,et al.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. , 1997, Science.

[17]  Alexander E. Kel,et al.  MATCHTM: a tool for searching transcription factor binding sites in DNA sequences , 2003, Nucleic Acids Res..

[18]  Neil J. McKenna,et al.  Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators , 2002, Cell.

[19]  C. Glass,et al.  Coregulator Codes of Transcriptional Regulation by Nuclear Receptors* , 2001, The Journal of Biological Chemistry.

[20]  Shi Huang,et al.  Inactivation of a histone methyltransferase by mutations in human cancers. , 2003, Cancer research.

[21]  E. Avvedimento,et al.  DNA Oxidation as Triggered by H3K9me2 Demethylation Drives Estrogen-Induced Gene Expression , 2008, Science.

[22]  C. Napoli,et al.  Silencing of YY1 downregulates RIZ1 promoter in human osteosarcoma. , 2008, Oncology research.

[23]  A. Chambery,et al.  Proteomic analysis of MCF-7 cell lines expressing the zinc-finger or the proline-rich domain of retinoblastoma-interacting-zinc-finger protein. , 2006, Journal of proteome research.

[24]  L. Liu,et al.  The Retinoblastoma Interacting Zinc Finger Gene RIZ Produces a PR Domain-lacking Product through an Internal Promoter* , 1997, The Journal of Biological Chemistry.

[25]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[26]  P. Rigby,et al.  Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses. , 1988, Genes & development.

[27]  Guohua Wang,et al.  Estradiol-regulated microRNAs control estradiol response in breast cancer cells , 2009, Nucleic acids research.

[28]  J. Thomsen,et al.  Mechanisms of estrogen action. , 2001, Physiological reviews.

[29]  R. Chadwick,et al.  Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. , 2001, Genes & development.

[30]  G. de Rosa,et al.  Expression of RIZ1 protein (Retinoblastoma‐interacting zinc‐finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2 , 2009, Journal of cellular physiology.

[31]  P. Herrlich,et al.  Transcriptional cross-talk, the second mode of steroid hormone receptor action , 1998, Journal of Molecular Medicine.

[32]  Liusheng,et al.  RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. , 1998, Cancer research.

[33]  Y. Hayashizaki,et al.  Identification of the Syrian hamster cardiomyopathy gene. , 1997, Human molecular genetics.

[34]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[35]  Clifford A. Meyer,et al.  Genome-wide analysis of estrogen receptor binding sites , 2006, Nature Genetics.

[36]  T. Furukawa,et al.  RIZ, the retinoblastoma protein interacting zinc finger gene, is mutated in genetically unstable cancers of the pancreas, stomach, and colorectum , 2001, Genes, chromosomes & cancer.

[37]  B. O’Malley,et al.  Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.

[38]  E. Wingender,et al.  MATCH: A tool for searching transcription factor binding sites in DNA sequences. , 2003, Nucleic acids research.

[39]  A. Puca,et al.  Identification of a DNA binding protein cooperating with estrogen receptor as RIZ (retinoblastoma interacting zinc finger protein). , 1999, Biochemical and biophysical research communications.

[40]  S. Huang,et al.  The retinoblastoma protein-interacting zinc finger gene RIZ in 1p36-linked cancers. , 1999, Frontiers in bioscience : a journal and virtual library.

[41]  S. Huang,et al.  The yin-yang of PR-domain family genes in tumorigenesis. , 2000, Histology and histopathology.

[42]  Gratien G. Prefontaine,et al.  Histone Methylation-Dependent Mechanisms Impose Ligand Dependency for Gene Activation by Nuclear Receptors , 2007, Cell.

[43]  Martin C Frith,et al.  Genomic targets of nuclear estrogen receptors. , 2004, Molecular endocrinology.

[44]  R. Marmorstein.  Structure of SET domain proteins: a new twist on histone methylation. , 2003, Trends in biochemical sciences.

[45]  C. Glass,et al.  A Topoisomerase IIß-Mediated dsDNA Break Required for Regulated Transcription , 2006, Science.

[46]  Myles Brown,et al.  Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription , 2000, Cell.

[47]  P. Chambon,et al.  Cooperation of proto‐signals for nuclear accumulation of estrogen and progesterone receptors. , 1992, The EMBO journal.

[48]  S. McKnight,et al.  Eukaryotic transcriptional regulatory proteins. , 1989, Annual review of biochemistry.

[49]  A. Puca,et al.  The retinoblastoma-interacting zinc-finger protein RIZ is a downstream effector of estrogen action. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[50]  H. Hirai.  The transcription factor Evi-1. , 1999, The international journal of biochemistry & cell biology.

[51]  G. Puca,et al.  The Zn-finger domain of RIZ protein promotes MCF-7 cell proliferation. , 2004, Cancer letters.

[52]  R. Shiu,et al.  Mechanism of estrogen activation of c-myc oncogene expression. , 1992, Oncogene.

[53]  S. Safe,et al.  Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation. , 1998, Endocrinology.

[54]  Takuro Nakamura,et al.  A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation. , 2003, Blood.

[55]  Brian J. Smith,et al.  RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma , 2006, Cancer.

[56]  P. Chambon,et al.  The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. , 1989, The EMBO journal.

[57]  M. Bainbridge,et al.  RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines , 2007, Oncogene.